185 related articles for article (PubMed ID: 21306323)
1. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
[TBL] [Abstract][Full Text] [Related]
2. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.
Baandrup L; Faber MT; Aalborg GL; Kjaer SK
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027
[TBL] [Abstract][Full Text] [Related]
3. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
4. Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study.
Hannibal CG; Frederiksen K; Vang R; Kurman RJ; Kjaer SK
Int J Cancer; 2020 Aug; 147(4):990-995. PubMed ID: 31930502
[TBL] [Abstract][Full Text] [Related]
5. Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study.
Guleria S; Jensen A; Kjær SK
Gynecol Oncol; 2018 Jan; 148(1):86-90. PubMed ID: 29174556
[TBL] [Abstract][Full Text] [Related]
6. Ovarian and tubal cancer in Denmark: an update on incidence and survival.
Gottschau M; Mellemkjaer L; Hannibal CG; Kjaer SK
Acta Obstet Gynecol Scand; 2016 Oct; 95(10):1181-9. PubMed ID: 27454324
[TBL] [Abstract][Full Text] [Related]
7. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
[TBL] [Abstract][Full Text] [Related]
8. Epithelial ovarian cancer subtypes attributable to smoking in the Norwegian Women and Cancer Study, 2012.
Licaj I; Lukic M; Jareid M; Lund E; Braaten T; Gram IT
Cancer Med; 2016 Apr; 5(4):720-7. PubMed ID: 26762486
[TBL] [Abstract][Full Text] [Related]
9. Coffee, tea, and caffeine consumption and risk of epithelial ovarian cancer and borderline ovarian tumors: Results from a Danish case-control study.
Gosvig CF; Kjaer SK; Blaakær J; Høgdall E; Høgdall C; Jensen A
Acta Oncol; 2015; 54(8):1144-51. PubMed ID: 25629440
[TBL] [Abstract][Full Text] [Related]
10. Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study.
Guleria S; Jensen A; Toender A; Kjaer SK
Cancer Causes Control; 2020 Jan; 31(1):25-31. PubMed ID: 31673820
[TBL] [Abstract][Full Text] [Related]
11. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.
Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY
J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007.
Kalapotharakos G; Högberg T; Bergfeldt K; Borgfeldt C
Acta Obstet Gynecol Scand; 2016 Apr; 95(4):473-9. PubMed ID: 26714557
[TBL] [Abstract][Full Text] [Related]
13. Non-epithelial ovarian cancer in Denmark - Incidence and survival over nearly 40 years.
Bennetsen AKK; Baandrup L; Aalborg GL; Kjaer SK
Gynecol Oncol; 2020 Jun; 157(3):693-699. PubMed ID: 32223987
[TBL] [Abstract][Full Text] [Related]
14. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma.
Hannibal CG; Vang R; Junge J; Frederiksen K; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Jan; 144(1):174-180. PubMed ID: 27836204
[TBL] [Abstract][Full Text] [Related]
15. Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark.
Hannibal CG; Baandrup L; Hertzum-Larsen R; Vang R; Kurman RJ; Frederiksen K; Kjaer SK
Int J Cancer; 2023 Apr; 152(7):1370-1377. PubMed ID: 36366853
[TBL] [Abstract][Full Text] [Related]
16. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.
Skírnisdóttir I; Garmo H; Wilander E; Holmberg L
Int J Cancer; 2008 Oct; 123(8):1897-901. PubMed ID: 18661518
[TBL] [Abstract][Full Text] [Related]
17. [Serous and mucinous epithelial ovarian tumors--a clinicopathologic study of 116 cases].
Giurgea NL; Pitrop M; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):389-94. PubMed ID: 23077925
[TBL] [Abstract][Full Text] [Related]
18. Is Pelvic Inflammatory Disease a Risk Factor for Ovarian Cancer?
Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):104-109. PubMed ID: 27672055
[TBL] [Abstract][Full Text] [Related]
19. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries.
Kjaerbye-Thygesen A; Huusom LD; Frederiksen K; Kjaer SK
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):1006-12. PubMed ID: 16167920
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study.
Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
Gynecol Oncol; 2016 Nov; 143(2):346-351. PubMed ID: 27549433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
